Influenza vaccination in 29 countries: An update to 1997

PharmacoEconomics

Volumn 16, Issue SUPPL. 1, 1999, Pages 47-54

  Ambrosch, Franz ^a   Fedson, David S ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Pasteur Merieux Connaught   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CONFERENCE PAPER; DRUG INDICATION; DRUG USE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; DEVELOPED COUNTRIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 0032715565     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916001-00007     Document Type: Conference Paper

References (16)

1. Fedson DS, Leese J, Hannoun C, et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 1995; 13: 623-7
2. Fedson DS, Hirota Y, Shin HK, et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997; 15: 1506-11
3. OECD Health Data 97, Paris: OECD Publications Service, 1997
4. Reinders A, Postma MJ, Govaert TME, et al. Kosteneffectiviteit van influenza vaccinatie in Nederland. Ned Tijdschr Geneeskd 1997; 141: 93-7
5. Immunisation Guidelines for Ireland. 1996 edition. Dublin: Royal College of Physicians of Ireland, 1996
6. Hannoun C. Le vaccin antigrippal d'aujourd'hui et de demain. Virologie 1997; 1: 121-31
7. CROSP. La Sangté de la population: Enquéte de santé. Brussels: CROSP Scientific Institute of Public Health - Louis Pasteur, 1997: 31
8. Pregliasco F, Soldano L, Mensi C, et al. Influenza vaccination among the elderly in Italy. Bull World Health Org 1999; 77: 127-31
9. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged ≥65 years - United States, 1997. Morbid Mortal Weekly Rep MMWR 1998; 47: 797-802
10. Scott WG, Scott HM, Economic evaluation of vaccination against influenza in New Zealand. Pharmacoeconomics 1996; 9: 51-60
11. Nichol KL, Wuorenma J, Von Sternberg T. The benefits of influenza vaccination for low-, intermediate- and high-risk senior citizens. Arch Intern Med 1998; 158: 1769-76
12. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination program for elderly persons: cost-effectiveness in a health maintenance organisation. Ann Intern Med 1994; 121: 947-52
13. Diguiseppi C. Why everyone over 65 deserves influenza vaccine. BMJ 1995; 1162: 313
14. Calman C, Moores Y. Influenza immunisation: extension of current policy to include all those aged 75 years and over. London: Department of Health, 1998 (PL/CMO/98/4)
15. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944-50
16. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18: 64-76